Preparing for disease-modifying therapies in Alzheimer's disease

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

Liu, E., Zhang, Y., & Wang, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 220 · see citing works

Global Burden of Alzheimer's disease and other dementias in adults aged 65 years and older, 1991–2021: population-based study

Xiaopeng, Z., Yu, J., Xia, L., Wang, X., Juan, D., long, Y. N., & Baoshan, L. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1585711 · Cited by 93 · see citing works

Diets to promote healthy brain ageing

Charisis, S., Yannakoulia, M., & Scarmeas, N. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01036-9 · Cited by 60 · see citing works

Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease

Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2024) · Molecules · doi:10.3390/molecules29215131 · Cited by 56 · see citing works

Disease modification in chronic spontaneous urticaria

Maurer, M., Kolkhir, P., Pereira, M. P., Siebenhaar, F., Witte‐Händel, E., Bergmann, K., Bonnekoh, H., Buttgereit, T., Fluhr, J. W., Frischbutter, S., et al. (2024) · Allergy · doi:10.1111/all.16243 · Cited by 55 · see citing works

Dementia classification using a graph neural network on imaging of effective brain connectivity

Cao, J. H., Yang, L., Sarrigiannis, P. G., Blackburn, D. J., & Zhao, Y. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107701 · Cited by 34 · see citing works

Ellagic Acid: A Green Multi-Target Weapon That Reduces Oxidative Stress and Inflammation to Prevent and Improve the Condition of Alzheimer’s Disease

Alfei, S., & Zuccari, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020844 · Cited by 28 · see citing works

Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum. A systematic review and meta-analysis

Antonioni, A., Raho, E. M., Lorenzo, F. D., Manzoli, L., Flacco, M. E., & Koch, G. (2025) · Journal of Neurology · doi:10.1007/s00415-025-12996-3 · Cited by 28 · see citing works

Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer’s disease to individuals with mild cognitive impairment or early Alzheimer’s disease in the general population

Claus, J. J., Hofe, I. V., Veenstra, A. V. I., Licher, S., Seelaar, H., de Jong, F. J., Neitzel, J., Vernooij, M. W., Ikram, M. A., & Wolters, F. J. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01220-1 · Cited by 24 · see citing works

Clinical Benefits and Risks of Antiamyloid Antibodies in Sporadic Alzheimer Disease: Systematic Review and Network Meta-Analysis With a Web Application

Jeremic, D., Navarro‐López, J. D., & Jiménez‐Díaz, L. (2025) · Journal of Medical Internet Research · doi:10.2196/68454 · Cited by 14 · see citing works

Nasal nanotherapeutics for central nervous system disorders: Bridging the translational gap in central nervous system drug delivery

Zhang, Y.-B., Liu, M., Wang, Y., Hu, D., Wu, S., Zhao, B., Zhou, B., & Yang, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177958 · Cited by 13 · see citing works

Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey

Boumali, R., Urli, L., Naïm, M., Soualmia, F., Kinugawa, K., Petropoulos, I., & Amri, C. E. (2024) · Biochimie · doi:10.1016/j.biochi.2024.04.001 · Cited by 12 · see citing works

What will it take to achieve brain health globally?

Gorelick, P. B., Hainsworth, A. H., & Wallin, A. (2024) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2024.100209 · Cited by 11 · see citing works

Identifying Genetic Risk for Amyloid-Related Imaging Abnormalities

Hardy, J., & Schott, J. M. (2023) · Neurology · doi:10.1212/wnl.0000000000208096 · Cited by 10 · see citing works

Developing disease-modifying interventions in idiopathic REM sleep behavior disorder and early synucleinopathy

Arnaldi, D., Iranzo, Á., Nobili, F. M., Postuma, R. B., & Videnović, A. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107042 · Cited by 9 · see citing works

Healthcare providers perspectives and perceptions of dementia diagnosis and management at the Aga Khan University Hospital, Nairobi, Kenya

Bosire, E. N., Blackmon, K., Kamau, L. W., Udeh‐Momoh, C. T., Sokhi, D. S., Shah, J., Mbugua, S., Muchungi, K., Meier, I. B., Narayan, V. A., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251320411 · Cited by 8 · see citing works

Lecanemab appropriate use recommendations for clinical practice in the UK

Mummery, C. J., Rasmussen, J., Blackburn, D. J., Coulthard, E. J., Davies, R., Dorsey, R., Fox, N. C., Hosseini, A. A., Ivenso, C., Jones, M. S., et al. (2025) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2025-336597 · Cited by 11 · see citing works

Promoting Growth in Behavioral Neurology: A Path Forward

Bateman, J. R., Josephy‐Hernandez, S. E., Apostolova, L. G., Benjamin, S., Barrett, A. M., Boeve, B. F., Budson, A. E., Chemali, Z. N., Lin, C.-Y. R., Daffner, K. R., et al. (2024) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000368 · Cited by 8 · see citing works

Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions

Greenberg, B., Lemere, C. A., Barnes, L. L., Hayden, K. M., Kukull, W. A., Oh, E. S., Snyder, P. J., Supiano, M. A., & Dilworth‐Anderson, P. (2023) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12426 · Cited by 8 · see citing works

Sleep Disturbances Across Dementias and Cognitive Decline: Study Protocol for a Systematic Review and Network Meta-Analysis of Polysomnographic Findings

Antonioni, A., Valle, A. D., Leitner, C., Raho, E. M., Cesnik, E., Capone, J. G., Flacco, M. E., Casoni, F. M., Proserpio, P., Ferini‐Strambi, L., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207437 · Cited by 7 · see citing works

Dementia, more than a diagnosis and drugs: perspectives from primary care on the new therapeutic era for Alzheimer’s disease

Foley, T., Perry, M., & Robinson, L. A. (2025) · The Lancet Primary Care · doi:10.1016/j.lanprc.2025.100061 · Cited by 7 · see citing works

Ultrasensitive Alzheimer’s disease biomarker detection with nanopillar photonic crystal biosensors

de Arruda, G. S., Morris, K., Martins, A., Wang, Y., Sloan‐Dennison, S., Graham, D., Quinn, S. D., Martins, E. R., & Krauss, T. F. (2025) · Optica · doi:10.1364/optica.566672 · Cited by 7 · see citing works

Effectiveness and utilization of a cognitive screening program for primary geriatric care

Salmon, D. P., Malkina, A., Johnson, M. L., Gigliotti, C. M., Little, E. A., & Galasko, D. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01637-y · Cited by 9 · see citing works

Towards a new Value-based scenario for the management of dementia in Italy: a SINdem delphi consensus study

Marra, C., Beccia, F., Caffarra, P., L’Abbate, F., Agosta, F., Benussi, A., Bonanni, L., Bruni, A. C., Bruno, G., Cappa, S. F., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08143-5 · Cited by 6 · see citing works

Adverse events associated with lecanemab: A disproportionality analysis of data from the FDA adverse event reporting system

Li, J., Zhang, F., & Eisel, U. L. M. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251333084 · Cited by 6 · see citing works

Are current etiological theories of Alzheimer’s disease falsifiable? An epistemological assessment

Costa, T., & Liloia, D. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1708234 · Cited by 5 · see citing works

Human biomarker navigator

Li, M., Zhang, Q., Wang, Z., Gui, Z., Liu, J., Li, J., Jiang, M., Chang, Z., Han, Q., Yang, B., et al. (2026) · iMeta · doi:10.1002/imt2.70157 · Cited by 5 · see citing works

The Profile of the Italian Centers for Cognitive Disorders and Dementia in the Context of New Drugs in Alzheimer’s Disease

Giaquinto, F., Lorenzini, P., Salvi, E., Carnevale, G., Vaccaro, R., Matascioli, F., Corbo, M., Locuratolo, N., Vanacore, N., Bacigalupo, I., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240594 · Cited by 5 · see citing works

Association between BrainAGE and Alzheimer's disease biomarkers

Abughofah, Y., Deardorff, R. L., Vosmeier, A., Hottle, S., Dage, J. L., Dempsey, D. A., Apostolova, L. G., Brosch, J. R., Clark, D. G., Farlow, M. R., et al. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70094 · Cited by 6 · see citing works

Amyloid immunotherapy for Alzheimer's disease: the case for cautious adoption

Schott, J. M., & Marshall, C. R. (2025) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0045-1807718 · Cited by 4 · see citing works

Ultra‐fast MRI for dementia diagnosis and treatment eligibility: A prospective study

Rosa‐Grilo, M., Chughtai, H. R., Thomas, D. L., Alexander, D. C., Beament, M., Belder, C. R. S., Jäger, H. R., Lim, E., Magill, N., Mallon, D. H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70341 · Cited by 4 · see citing works

The Janus face of CaMKII: from memory consolidation to neurotoxic switch in Alzheimer’s disease

Tang, L., Liu, F., Sun, X., Yang, J., Liu, Y., Pan, X., Hao, L., Lou, F., & Su, J. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04160-7 · Cited by 5 · see citing works

The potential of low-field MRI for global dementia care

Evans, T. E., Harper, J. R., Salehi, A., WEBB, A. G., Cole, J. H., Correa, A., Adams, H. H. H., Cash, D. M., & Jones, D. K. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01199-7 · Cited by 4 · see citing works

Health System Readiness for Disease-Modifying Therapies for Alzheimer Disease

CDA-AMC (2024) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2024.1038 · Cited by 4 · see citing works

Super-resolution microscopy as a drug discovery tool

Toms, L., FitzPatrick, L., & Auckland, P. (2025) · SLAS DISCOVERY · doi:10.1016/j.slasd.2025.100209 · Cited by 4 · see citing works

Knowledge, Attitudes, and Practices of General Physicians towards Mild Cognitive Impairment amidst an evolving era of Interprofessional Collaboration: Insights from a small-scale survey in India

Soni, A., Carthik, P., Devara, M. K., Rooha, A., Bajaj, G., Moolambally, S. R., Shirali, A., & Boloor, A. (2025) · BMC Family Practice · doi:10.1186/s12875-025-02748-7 · Cited by 3 · see citing works

Innovations in dementia screening: a systematic review and meta-analysis of virtual reality assessments

Gausemel, Å., & Filkuková, P. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1606562 · Cited by 3 · see citing works

Implementation and service impact of anti-amyloid therapy in a psychiatry-led dementia care program: Real-world evidence from a Japanese regional dementia center

Otani, K., Ishihara, H., Nakamura, T., & KAWABE, K. (2026) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2026.04.006 · Cited by 3 · see citing works

Will Vietnamese American communities benefit from new Alzheimer's disease treatments?

Hoang, K., Meyer, O. L., & Grill, J. D. (2025) · Alzheimer s & Dementia Behavior & Socioeconomics of Aging · doi:10.1002/bsa3.70009 · Cited by 3 · see citing works

Brain DNA Methylation Atlas of App NL‐G‐F Alzheimer's Disease Model Mice Across Age and Region Reveals Choline‐Induced Resilience

Krunic, A., Bellio, T. A., Cohen, B. Z., Labadorf, A. T., Stein, T. D., Lin, H., Mellott, T. J., & Blusztajn, J. K. (2025) · Aging Cell · doi:10.1111/acel.70241 · Cited by 4 · see citing works

Reaching people and managing membership in community-based dementia support groups: the Get Real with Meeting Centres realist evaluation part 1

Morton, T. A., Evans, S., Swift, R., Bray, J., Frost, F., Russell, C., Brooker, D., Wong, G., & Hullah, N. (2024) · Aging & Mental Health · doi:10.1080/13607863.2024.2356885 · Cited by 3 · see citing works

A qualitative analysis of patients' day-to-day living with functional cognitive disorder (FCD).

Mantovani, N., Poole, N., Cope, S., Vanzan, S., Duffus, A., Williams, T., Smith, J. G., Barrett, B., Scicluna, M., Beardmore, S., et al. (2025) · Disability and Rehabilitation · doi:10.1080/09638288.2025.2460725 · Cited by 2 · see citing works

A national survey of dementia diagnosis and care in English memory services

Kelsey, O., Demnitz‐King, H., Kenten, C., Chapman, H., Muralidhar, M., Camboe, E., Whitfield, E. M., Zabihi, S., Williams, E., Jones, A., et al. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07155-w · Cited by 2 · see citing works

Alzheimer's disease immunotherapy and the amyloid hypothesis: when aggregation obscures interpretation

Fox, N. C., Kohlhaas, S. L., & Schott, J. M. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00789-0 · Cited by 2 · see citing works

Disease-modifying effect of donepezil on APP/PS1 mice at different stages of Alzheimer’s disease

Zueva, I. V., Belyaev, G. P., & Petrov, K. A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05310-2 · Cited by 2 · see citing works

The Cognitive Change Index in the Alzheimer's Disease Research Center setting: Self‐ and informant‐ratings for perceived cognitive decline

Abughofah, Y., Risacher, S. L., Unverzagt, F. W., Farlow, M. R., Apostolova, L. G., Brosch, J. R., Clark, D. G., Mathew, S., Gao, S., Wang, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70754 · Cited by 1 · see citing works

Editorial: Impacts of public-private collaborative research on Alzheimer's disease: the case of the innovative medicines initiative

Vaudano, E., Georges, J., Hofmann‐Apitius, M., & Lo, D. C. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1321225 · Cited by 2 · see citing works

APOE E4 Alzheimer’s Risk Converges on an Oligodendrocyte Subtype in the Human Entorhinal CortexPreprint

Huuki-Myers, L. A., Divecha, H. R., Bach, S. V., Valentine, M. R., Eagles, N. J., Mulvey, B., Bharadwaj, R. A., Zhang, R., Evans, J. R., Grant‐Peters, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.20.689483 · Cited by 3 · see citing works

How Disease‐Modifying Therapies Challenge Dementia Care Continuity in Japan: From Promise to Paradox

Ito, K., Hatakeyama, A., & Okamura, T. (2025) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70098 · Cited by 1 · see citing works

MSSAFN: A multiscale structure-aware spatial fusion network for Alzheimer’s disease classification

Huang, Y., Duan, B., Li, Z., & Zhang, Q. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.108889 · Cited by 1 · see citing works

Establishment of a second-generation transgenic marmoset with germline transmission that models polyglutamine disease

Minakawa, E. N., Owari, K., Nogami, N., Nakatani, T., Koizumi, M., Kawanobe, A., Saga, Y., Kudo, M., Noguchi, S., Hanakawa, T., et al. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052470 · Cited by 1 · see citing works

The capacity for Alzheimer's disease confirmatory testing in the United States: The current situation and simulations for future increase

Roth, S., Yan, J. T., Patru, M.-M., Mattke, S., Gustavsson, A., & Ortsäter, G. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251406909 · Cited by 1 · see citing works

CTAD 2025: Key trends redefining therapeutic and diagnostic strategies in Alzheimer's disease

Yuan, M., & Zhou, H.-Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261430764 · Cited by 1 · see citing works

The role of placebo control in clinical trials for neurodegenerative diseases

Mehta, A. R., Carpenter, J. R., Nicholas, J. M., Chataway, J., Virgo, B., Parmar, M., Chandran, S., & Pal, S. (2023) · Nature Medicine · doi:10.1038/d41591-023-00080-0 · Cited by 1 · see citing works

Establishment of a second-generation transgenic marmoset model of polyglutamine disease recapitulating neurological symptoms and pathologyPreprint

Minakawa, E. N., Owari, K., Nogami, N., Nakatani, T., Koizumi, M., Kawanobe, A., Saga, Y., Kudo, M., Noguchi, S., Hanakawa, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.12.642922 · Cited by 1 · see citing works

Reaffirming the vision of the journal and recognizing our heroes

Han, S. D. (2025) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbaf113 · Cited by 1 · see citing works

A Self-Administered Digital Test Battery for Early Detection of Cognitive Impairment in Alzheimer’s DiseasePreprint

Rutt, S., Taute, M., Tegethoff, P., Perneczky, R., Kurz, C., & Rauchmann, B. (2025) · medRxiv · doi:10.1101/2025.07.16.25331196 · Cited by 1 · see citing works

Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer’s disease to individuals with MCI or early AD in the general populationPreprint

Claus, J. J., Hofe, I. V., Veenstra, A. V. I., Licher, S., Seelaar, H., de Jong, F. J., Neitzel, J., Vernooij, M. W., Ikram, M. A., & Wolters, F. J. (2024) · medRxiv · doi:10.1101/2024.02.29.24303553

Targeting modifiable risk and protective factors to prevent dementia

Asbroeck, S. V. (2024) · doi:10.26481/dis.20240618sa

Review of recently published articles

Oseji, D. (2024) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2024.0024

Development and validation of a self-administered computerized cognitive assessment based on automatic speech recognition

Kong, H. H., Shin, K., Yang, D., Kim, A., Joo, H.-S., Oh, M. W., & Lee, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315745

The role of the nursing team of the Neurosciences Group of Antioquia (GNA) in the execution of the prevention clinical trial for early-onset familial Alzheimer’s disease in Colombia

Madrigal, L., Mesa, C. C. M., Álvarez, É. G., Roldán, A. N., Jiménez, Y. B., Piedrahita, F., Agudelo, J. R., Aguillon, D. F., Ramos, C., Romenets, S. R., et al. (2025) · ScienceBank · doi:10.61340/rntnga

The iADRS as an integrated measure of cognition and function: Psychometric evidence from recent clinical trials in early symptomatic Alzheimer's disease

Atkins, A. S., Marquis, S., Creel, K., Meunier, J., Cano, S., Delbecque, L., Shan, M., & Wessels, A. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70656

Impact of socio-economic and patient-centered characteristics on access to Alzheimer's disease medication in primary care: A population-based study in the Stockholm county, Sweden

Shaker, A., Ljunggren, G., Vossen, L. E., Religa, D., & Raaschou, P. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251375900

Investigating the Impact of ABCB1 3435C>T (rs1045642) Variant on Severity and Cognitive Decline in Egyptian Alzheimer’s Disease Patients

Farouk, Y., Nagy, N., Amir, A. M. E., Madbouly, N. A., & El-Khazragy, N. N. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05789-w

Reframing dementia care in the era of disease-modifying therapies: informational, psychosocial, and systemic insights from Japan

Ito, K., Tsuda, S., Wake, T., Hatakeyama, A., Ogisawa, F., Ono, M., Nakayama, R., Wakui, T., Nagano, N., & Iwata, A. (2026) · BMC Health Services Research · doi:10.1186/s12913-026-14472-8

Understanding the Scope of Health System Use in People Living with Young-Onset Dementia

Sullivan, M. P., Williams, V., Savage, D. W., Lalva, T., Cerasuolo, J. O., & Bronskill, S. E. (2026) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2026.10607

Demographic, Social, and Clinical Profiles of Patients Initiating Lecanemab in Clinical Practice: A Single-Center Experience in Korea

Lee, J., Kim, H., Park, H. K., Kim, S., Lee, K. B., Kang, H., Shin, D., Kim, J. P., & Lee, B. H. (2026) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2026.25.2.134

MMSE–CDR‐SB residual as an exploratory indicator of deviation from an Alzheimer's disease–typical cognitive–functional pattern

Mounié, A., Sato, K., Nakashima, S., Kurihara, M., Ihara, R., Niimi, Y., Iwata, A., & Iwatsubo, T. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70460

ODIN Biobank: a Danish cohort for dementia research- cohort profile

Laugesen, K., Skjærbæk, C., Okkels, N., Møller, H. J., Borghammer, P., Gottrup, H., & Parkner, T. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-114084

Pilot feasibility, acceptability, and tolerability of researcher-delivered apolipoprotein E ( APOE ) disclosure via videoconferencing in Australian adults at-risk of dementia

Rosenich, E., Chauhan, S., Haeusler, R., Keriakes, M., Cummins, H., Olver, H., Bransby, L., Maruff, P. T., & Lim, Y. Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261459068

Identifying facility-level and infrastructure-level bottlenecks in Japan's lecanemab rollout through an online survey of dementia specialists

Nakashima, S., Sato, K., Niimi, Y., Ihara, R., Iwata, A., Nemoto, K., Arai, T., Higashi, S., Igarashi, A., Kasuga, K., et al. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261470054

Global trends in Alzheimer's and dementia research (2019–2024): A machine learning-based bibliometric analysis

Scerri, A., Scerri, K., & Scerri, C. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261471922

Digital twins in geriatrics and gerontology: Applications, challenges, and future directions

Faronbi, G. O., James, E., Matope, E. M., Bamidele, D. B., Alabi, J. O., & Olawade, D. B. (2026) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2026.106371

Stakeholders' perspectives on an autonomous brain MRI: An interview study

Mensinga, C. N., Visser, L. N. C., Ebbers, J., Winters, S. A. C. M., Klomp, D. W. J., Emmelot‐Vonk, M. H., & Koek, H. L. (2026) · PEC Innovation · doi:10.1016/j.pecinn.2026.100496

Towards a future without dementia

Spires‐Jones, T. L. (2026) · doi:10.1093/9780198995296.003.0008

Novel therapies in Alzheimer’s disease

Pavăl, D., Căpățînă, O., & Stănculete, M. F. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.026

Posttraumatic Stress Disorder, Health-Related Social Needs, and Cognitive Outcomes in US Veterans

Ouyang, F., Pogoda, T. K., Reisman, J. I., Li, R., Pradhan, R., Moradi, Y., Mez, J. B., Liu, W., Zhang, Y., Sultana, S., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.34839

Rural-urban disparities in the clinical diagnostic pathway of patients with all-cause mild cognitive impairment and dementia due to Alzheimer's disease in Australia

Lin, X., Honardoost, M. A., Ahern, S., Taylor, C. B., Ward, S. A., de Laguiche, E., Adesanya, E., Brodaty, H., Pearson‐Stuttard, J., Holloway, S., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261489828

Fluid amyloid-β (Aβ) biomarkers reflect early β-sheet-rich Aβ deposition during the preclinical stage in Alzheimer's disease model 5XFAD mice

Yagihara, H., 祐幸, 齋., Takeuchi, T., Seki, K., & Minakawa, E. N. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.116044

Peripheral hematological inflammatory signatures in the amyloid-defined Alzheimer’s disease continuum: associations with disease stage, cognitive function, and astroglial activation

He, Y., Zhou, J., Wu, X., 盛静, Zhang, Z., Feng, Z., & Zhang, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1959479

Occupational therapists’ views on the existing and potential use of multifunctional robots in dementia rehabilitation

Maclean, F., Ryan, C., Hunter, E., Dragone, M., Paton, L., Gray, A., & Porter-Armstrong, A. P. (2026) · British Journal of Occupational Therapy · doi:10.1177/03080226261490738

Cerebrospinal Fluid Biomarker Ratio Concordance with Amyloid Positron-Emission Tomography: A Diagnostic Test Accuracy Meta-analysis

Martinez-Lage, P., Solje, E., Martins, J. G., Guess, M., & Sarkar, S. (2026) · Neurology and Therapy · doi:10.1007/s40120-026-01056-1

Lecanemab: A novel disease-modifying drug treatment for Alzheimer’s disease

Bhanwra, S., & Mahajan, S. S. (2024) · National Journal of Pharmacology and Therapeutics · doi:10.4103/njpt.njpt_17_24 · Cited by 1 · see citing works

Emerging and Disease-Modifying Treatments for Alzheimer’s Disease: Current Evidence, Safety, and Future Directions

Stefański, M., Racki, E., Traczyk, N., Wiak, B., Jaguszewska, J., Wieliczko, K., Natalia Zych, M. J.-H., Izabela Truchel, J. S., Monika Łapot, W. G., Nataliia Yushchuk, A. I., et al. (2026) · African Journal of Biomedical Research · doi:10.69980/p3pezf52

New era in Alzheimer's disease therapeutics: transitioning from symptomatic management to disease-modifying paradigms

Xiao-chun, C., & Jiang-feng, L. (2026) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.3969/j.issn.1672⁃6731.2026.02.002

Advances in Alzheimer’s Disease Therapeutics: A Global Perspective

Cummings, J. L. (2024) · International Psychogeriatrics · doi:10.1017/s104161022400098x · Cited by 2 · see citing works

Monoclonal antibodies for early Alzheimer disease: a long road to discovery and marketing approval, a short timeline for health systems to organise services

Cagnin, A., Benussi, A., Marra, C., Bonanni, L., Bozzali, M., The SINdem Group, Agosta, F., Arighi, A., Bellelli, G., Bessi, V., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08577-x · Cited by 2 · see citing works